U.S. Panel Seen Backing Pfizer Inc.’s Arthritis Drug Hope

Pfizer Inc's experimental rheumatoid arthritis drug goes before an advisory panel next week, a potential blockbuster medicine that would revive faith in the company's research if its benefits are deem…
Read the full story: BioSpace.com Featured News